Difference between revisions of "Upper tract urothelial carcinoma"

From Libre Pathology
Jump to navigation Jump to search
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
'''Upper tract urothelial carcinoma''', is a [[urothelial carcinoma]] that involves the upper urinary tract (ureter, pelvis, kidney). It is a considered a rare disease.<ref name=pmid24319507>{{cite journal |authors=Kapoor A, Allard CB, Black P, Kassouf W, Morash C, Rendon R |title=Canadian guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma |journal=Can Urol Assoc J |volume=7 |issue=9-10 |pages=306–11 |date=2013 |pmid=24319507 |pmc=3854466 |doi=10.5489/cuaj.1578 |url=}}</ref>
'''Upper tract urothelial carcinoma''' (abbreviated '''UTUC'''), is a [[urothelial carcinoma]] that involves the upper urinary tract (ureter, pelvis, kidney). It is a considered a rare disease.<ref name=pmid24319507>{{cite journal |authors=Kapoor A, Allard CB, Black P, Kassouf W, Morash C, Rendon R |title=Canadian guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma |journal=Can Urol Assoc J |volume=7 |issue=9-10 |pages=306–11 |date=2013 |pmid=24319507 |pmc=3854466 |doi=10.5489/cuaj.1578 |url=}}</ref>


==General==
==General==
*Low-grade UCC may be managed via endoscopic approaches.<ref>{{cite journal |authors=Argyropoulos AN, Tolley DA |title=Upper urinary tract transitional cell carcinoma: current treatment overview of minimally invasive approaches |journal=BJU Int |volume=99 |issue=5 |pages=982–7 |date=May 2007 |pmid=17437430 |doi=10.1111/j.1464-410X.2007.06870.x |url=}}</ref>
*Low-grade upper tract urothelial carcinoma may be managed via endoscopic approaches.<ref name=pmid17437430>{{cite journal |authors=Argyropoulos AN, Tolley DA |title=Upper urinary tract transitional cell carcinoma: current treatment overview of minimally invasive approaches |journal=BJU Int |volume=99 |issue=5 |pages=982–7 |date=May 2007 |pmid=17437430 |doi=10.1111/j.1464-410X.2007.06870.x |url=}}</ref>
*May be associated with [[Lynch syndrome]] - [[MMR testing]] typically indicated.
*May be associated with [[Lynch syndrome]] - [[MMR testing]] typically indicated.



Latest revision as of 18:34, 3 September 2024

Upper tract urothelial carcinoma (abbreviated UTUC), is a urothelial carcinoma that involves the upper urinary tract (ureter, pelvis, kidney). It is a considered a rare disease.[1]

General

  • Low-grade upper tract urothelial carcinoma may be managed via endoscopic approaches.[2]
  • May be associated with Lynch syndrome - MMR testing typically indicated.

See also

References

  1. Kapoor A, Allard CB, Black P, Kassouf W, Morash C, Rendon R (2013). "Canadian guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma". Can Urol Assoc J 7 (9-10): 306–11. doi:10.5489/cuaj.1578. PMC 3854466. PMID 24319507. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854466/.
  2. Argyropoulos AN, Tolley DA (May 2007). "Upper urinary tract transitional cell carcinoma: current treatment overview of minimally invasive approaches". BJU Int 99 (5): 982–7. doi:10.1111/j.1464-410X.2007.06870.x. PMID 17437430.